Article

Eric Langer

Eric Langer is a member of Pharmaceutical TEchnology's editorial advisory board.

Mr. Eric Langer
President and Managing Partner
BioPlan Associates

Eric Langer is president and managing partner of BioPlan Associates (Rockville, MD), a biotechnology and life-sciences marketing company that provides information, market research, pricing, and market analysis to biotechnology and healthcare organizations. Eric cofounded BioPlan Associates in 1989.

He has more than 20 years of experience in biotechnology and life-sciences international marketing, management, market assessment, and publishing, which includes senior management and marketing positions at biopharmaceutical supply companies. He has launched and managed marketing programs for product lines ranging from $500,000 to $500 million.

Eric has published, edited, and authored numerous books, reports, and major studies on a variety of topics including: advances in biopharmaceutical technology in China, advances in large-scale biopharmaceutical manufacturing, biopharmaceuticals in the US market, cell-culture, media, sera, tissue engineering, stem cells, diagnostic products, blood products, genetics, DNA/PCR purification, and blood components. He also lectures extensively on pricing and channel-management topics and teaches at Johns Hopkins University and American University.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content